Replies to post #2865 on RedHill Biopharma Ltd (RDHL)

[midastouch017]

And finally, slide 8, investors often ask us, what are our goals for the next several years? What is our vision of what we want to become? Our goal is to become a leading US specialty pharma company. And we are well on our way to achieve that. The way we are doing that is continuing to commercialize our three FDA approved products and also developing our pipeline, which is our future engine of growth. We will do it by continuing to focus on detail orientated execution speed. We have done a good job of growing inorganically and organically. In other words, acquiring products such as Movantik from AstraZeneca at the commercial stage, and also developing products in-house such as Talicia as we have proven successfully to-date and taking these drugs all the way through. We will continue with that strategy into the future. We are here to build a leading specialty pharma company of the future.